® COPD Learn More Breathe Better is a registered trademark of the U.S. Department of Health and Human Services.
The NHLBI "Grand Opportunity" Exome Sequencing Project
Clinical trials are research studies that explore whether a medical strategy, treatment, or device is safe and effective for humans. To find clinical trials that are currently underway for COPD, visit www.clinicaltrials.gov.
November 21, 2012
CDC and NIH survey provides first report of state-level COPD prevalence
The age-adjusted prevalence of chronic obstructive pulmonary disease (COPD) varies considerably within the United States, from less than 4 percent of the population in Washington and Minnesota to more than 9 percent in Alabama and Kentucky. These state-level rates are among the COPD data available for the first time as part of the newly released 2011 Behavioral Risk Factor Surveillance System (BRFSS) survey.
If you have COPD or think you might be at risk, you can take steps to make breathing easier and live a longer and more active life. Get a simple breathing test and talk with your doctor or health care provider about treatment options.
The NHLBI developed the national COPD Learn More Breathe Better® campaign to increase awareness of COPD. The campaign aims to help people with COPD and those at risk get diagnosed early, understand their treatment options, and live better with the disease.
Learn more about key campaign events, activities, and resources.
The NHLBI updates Health Topics articles on a biennial cycle based on a thorough review of research findings and new literature. The articles also are updated as needed if important new research is published. The date on each Health Topics article reflects when the content was originally posted or last revised.